Ethics and drug resistance : : collective responsibility for global public health / / editors, Euzebiusz Jamrozik, Michael Selgelid.

This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major t...

Full description

Saved in:
Bibliographic Details
Superior document:Public Health Ethics Analysis, 5
:
HerausgeberIn:
Place / Publishing House:Cham : : Springer International Publishing :, Imprint: Springer,, 2020.
Year of Publication:2020
Edition:1st edition 2020.
Language:English
Series:Public Health Ethics Analysis, 5
Physical Description:1 online resource (XVII, 448 p. 1 illus.)
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Introduction
  • Part 1 Theoretical and conceptual approaches to ethics in antimicrobial resistance
  • Chapter 1 The practical ethics of antimicrobial resistance as a collective action problem (Julian Savulescu)
  • Chapter 2 Collective responsibility for antimicrobial resistance (Angus Dawson)
  • Chapter 3 Moral aspects of antimicrobial stewardship (Marcel Verweij)
  • Chapter 4 Ethical frameworks for rational antibiotic use (Annette Rid, Jasper Littmann, Alena Buyx)
  • Chapter 5 The virtuous physician as antimicrobial prescriber (Justin Oakley)
  • Chapter 6 Solidarity and compliance with antimicrobial policy (Søren Holm, Thomas Ploug)
  • Chapter 7 Resistance, inequality, and epidemiological transition (Lynette Reid)
  • Chapter 8 The price of precaution (Joakim Larsson, Christian Munthe)
  • Part 2 Ethics and antimicrobial resistance in context
  • Chapter 9 Hospital acquired infection (Lyn Gilbert & Ian Kerridge)
  • Chapter 10 Antibiotic use in childhood (Michael Millar)
  • Chapter 11 Ethics, animals, public goods (Jonny Anomaly)
  • Chapter 12 Malaria (PY Cheah& Mike Parker)
  • Chapter 13 Resistant HIV (Bridget Haire)
  • Chapter 14 Access & availability of new TB drugs (Diego Silva, Adrian Viens, Jasper Littmann)
  • Chapter 15 TB Resistance and Human rights (Leslie London)
  • Chapter 16 TB Resistance in developing countries (Richard Coker, Marco Liverani, Mishal Khan)
  • Chapter 17 Animal Epidemiology (Lisa Boden & Dominic Mellor)
  • Part 3 Ethical, legal and economic aspects of antimicrobial resistance
  • Chapter 18 Privacy and data collection(Leslie Francis)
  • Chapter 19 Mandatory treatment interventions (Carl Coleman)
  • Chapter 20 Ethics and AMR Regulation (Belinda Bennett)
  • Chapter 21 Ethics of Drug Development (Nick King)
  • Chapter 22 Economics of resistance (Coast/Smith)
  • Conclusion.